Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis
- PMID: 18785315
Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis
Abstract
Objective: To examine the precise tissue distribution of dendritic cells (DC) and indoleamine 2,3-dioxygenase (IDO)-expressing cells in synovial tissue and synovial fluid (SF) from patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
Methods: Synovial tissues from 30 patients with RA and 7 with OA were immunohistochemically stained for DC markers. The examined areas were classified into 5 categories based on pathobiological staging and histopathological grading systems. Myeloid DC (mDC) and plasmacytoid DC (pDC) were isolated using positive and negative magnetic sorting systems, respectively, from SF samples (7 patients with RA and 4 with OA) and synovial tissues (3 RA, 4 OA).
Results: mDC were mainly observed in lymphoid aggregations. pDC were scattered around perivenular infiltration areas, and small and large lymphoid aggregations in RA. The mDC/pDC ratio increased significantly, with higher grading in RA SF tissues compared to OA synovial tissues (p<0.05). IDO-immunoreactivity was detected in pDC by serial sectioning and staining of RA synovial tissues.
Conclusion: Our results indicate that mature mDC play a central role in the RA inflammatory process. Although there were fewer pDC than mDC, the presence of IDO-positive pDC suggests a possible tolerance mechanism in RA synovial tissues. However, it is probably modest due to the marked inflammation in RA, in which mDC are dominant.
Similar articles
-
Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines.Arthritis Rheum. 2000 Oct;43(10):2160-8. doi: 10.1002/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T. Arthritis Rheum. 2000. PMID: 11037875
-
Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.J Rheumatol. 2002 Mar;29(3):427-35. J Rheumatol. 2002. PMID: 11908553
-
Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.Cytokine. 2010 Jan;49(1):24-9. doi: 10.1016/j.cyto.2009.10.005. Epub 2009 Nov 25. Cytokine. 2010. PMID: 19942450
-
Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.Virchows Arch. 2002 Nov;441(5):415-27. doi: 10.1007/s00428-002-0702-1. Epub 2002 Nov 5. Virchows Arch. 2002. PMID: 12447670 Review.
-
[Macrophages in rheumatoid synovial membrane: an update].Rev Rhum Ed Fr. 1993 Oct;60(9):568-79. Rev Rhum Ed Fr. 1993. PMID: 8012331 Review. French.
Cited by
-
The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth.EPMA J. 2010 Mar;1(1):46-55. doi: 10.1007/s13167-010-0009-2. Epub 2010 Mar 19. EPMA J. 2010. PMID: 23199040 Free PMC article.
-
The synovium in rheumatoid arthritis.Open Rheumatol J. 2011;5:107-14. doi: 10.2174/1874312901105010107. Epub 2011 Dec 30. Open Rheumatol J. 2011. PMID: 22279509 Free PMC article.
-
Dendritic cells a double-edge sword in autoimmune responses.Front Immunol. 2012 Aug 2;3:233. doi: 10.3389/fimmu.2012.00233. eCollection 2012. Front Immunol. 2012. PMID: 22876246 Free PMC article.
-
Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.Clin Rheumatol. 2013 Jun;32(6):853-61. doi: 10.1007/s10067-013-2209-3. Epub 2013 Feb 10. Clin Rheumatol. 2013. PMID: 23397147
-
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.Immunotherapy. 2012 Oct;4(10):1053-61. doi: 10.2217/imt.12.117. Immunotherapy. 2012. PMID: 23148757 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials